Search
Dr Reddy's Laboratories Ltd
RDYAdd to Watchlist
14.910USD
+0.380+2.62%
Close 11-06 16:00（ET）
12.42BMarket Cap
25.58P/E TTM
Pre-market 07:06 (ET)14.880USD-0.030-0.20%
Pre-market 07:06 (ET)Dr Reddy's Laboratories Ltd (RDY) Stock Price Target & Forecast
Analyst Rating
Based on 4 analysts giving stock ratings to Dr Reddy's Laboratories Ltd in the past month.
Buy
1 Strong Buy
2 Buy
0 Hold
0 Sell
1 Strong Sell
Target Price
14.070USD-0.71%
RDY Analyst Recommendation Trends
In the current month, RDY has received 2 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. RDY average Analyst price target in the last month is 14.070.
2026-11
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
1
1
1
1
1
1
1
1
2
2
1
1
1
1
1
1
0
0
1
1
1
1
1
1
1
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
4
4
4
4
4
3
3
3
RDY Analyst Rating for Peer Comparison
Updated: Nov 5, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Biogen Inc
BIIB
8
16
12
1
0
37
Amgen Inc
AMGN
4
9
19
3
1
36
Eli Lilly and Co
LLY
10
19
3
1
0
33
Vertex Pharmaceuticals Inc
VRTX
10
17
5
0
1
33
Alnylam Pharmaceuticals Inc
ALNY
7
17
8
0
0
32
AbbVie Inc
ABBV
8
18
6
0
0
32
Neurocrine Biosciences Inc
NBIX
13
14
4
0
0
31
Merck & Co Inc
MRK
7
16
8
0
0
31
Bristol-Myers Squibb Co
BMY
5
6
18
1
0
30
Gilead Sciences Inc
GILD
7
18
5
0
0
30
Financial Forecasting
Based on analysts' estimates, RDY EPS is projected to reach 0.130 in FY2027Q3, following reported EPS of 0.116 in FY2027Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2026Q4
FY2027Q1
FY2027Q2
FY2027Q3
FY2027Q4
Forecast
0.10
0.09
0.09
0.13
0.13
Actual
0.03
0.06
0.12
--
--
Surprise
-69.97%
-36.52%
+27.47%
--
--
FAQs
What is Dr Reddy's Laboratories Ltd's expected revenue for the next quarter?
Dr Reddy's Laboratories Ltd's expected revenue is 949.43M.
What is Dr Reddy's Laboratories Ltd's price target?
Analysts forecast that Dr Reddy's Laboratories Ltd's price target is USD 14.07, with the highest forecast at USD 15.70 and the lowest forecast at USD 11.40.
How have Dr Reddy's Laboratories LtdRDY's recent earnings per share performed?
The market expectation was USD 0.12, while Dr Reddy's Laboratories LtdRDY's earnings per share (EPS) for the previous quarter was USD 0.06. EPS for the next quarter is expected at USD 0.13.
What is the analyst rating for Dr Reddy's Laboratories Ltd?
Based on the ratings of Dr Reddy's Laboratories Ltd's stock from 4 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.